person · Reporting owner
GTCR PARTNERS XI/A&C LP
Disclosed activity across 4 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director · 10% owner | May 28, 2024 | May 30, 2024 |
| Vivid Seats Inc.SEAT · Entity 7035 | 10% owner | October 31, 2025 | November 07, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date May 28, 2024 · Filed May 30, 2024
Jointly reported with GTCR INVESTMENT XI LLC, MARAVAI LIFE SCIENCES HOLDINGS, LLC, MARAVAI LIFE SCIENCES HOLDINGS 2, LLC, GTCR FUND XI/B LP, GTCR FUND XI/C LP, GTCR CO-INVEST XI LP, GTCR PARTNERS XI/B LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B common stockSEC Table I · non-derivative | IndirectSee footnotes | 110,684,080 |
Reported balance
After 2024-05-28 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-05-28 · Disposition to issuer · Disposed 8,409,946 · Balance 110,684,080 F1: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F2: Represents 110,684,080 shares of Class B common stock held directly by MLSH 1. F3: Shares of Class B common stock confer no economic rights on the holders thereof. Except as provided in the Issuer's Amended and Restated Certificate of Incorporation or as otherwise required by applicable law, holders of Class B common stock will be entitled to one vote per share on all matters to be voted on by holders of the Issuer's Class A common stock. Upon exchange of Common Units that are held by MLSH 1 and reported in Table II hereof, an equal number of shares of Class B common stock will be delivered to the Issuer and cancelled for no consideration. F4: Represents Class B common stock and Common Units held directly by MLSH 1 after giving effect to the exchange of 8,409,946 Common Units (and cancellation of an equal number of shares of Class B common stock) for 8,409,946 shares of Class A common stock. F7: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectSee footnotes | 30,090,979 |
Reported balance
After 2024-05-28 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-05-28 · Conversion · Acquired 8,409,946 · Balance 30,090,979 F1: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F7: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. |
| Class A common stockSEC Table I · non-derivative | IndirectSee footnotes | 20,150,005 |
Reported balance
After 2024-05-28 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-05-28 · Sale · Disposed 9,940,974 · Balance 20,150,005 F5: Represents (i) 8,409,946 shares of Class A common stock sold by MLSH 1 and (ii) 1,531,028 shares of Class A common stock sold by Maravai Life Sciences Holdings 2, LLC ("MLSH 2"). F6: Represents 20,150,005 shares of Class A common stock held directly by MLSH 2. F7: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. |
| Common UnitsSEC Table II · derivative / convertible security | IndirectSee footnotes | 110,684,080 |
Reported balance
After 2024-05-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2024-05-28 · Conversion · Disposed 8,409,946 · Balance 110,684,080 F1: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F4: Represents Class B common stock and Common Units held directly by MLSH 1 after giving effect to the exchange of 8,409,946 Common Units (and cancellation of an equal number of shares of Class B common stock) for 8,409,946 shares of Class A common stock. F7: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire.
F2: Represents 110,684,080 shares of Class B common stock held directly by MLSH 1.
F3: Shares of Class B common stock confer no economic rights on the holders thereof. Except as provided in the Issuer's Amended and Restated Certificate of Incorporation or as otherwise required by applicable law, holders of Class B common stock will be entitled to one vote per share on all matters to be voted on by holders of the Issuer's Class A common stock. Upon exchange of Common Units that are held by MLSH 1 and reported in Table II hereof, an equal number of shares of Class B common stock will be delivered to the Issuer and cancelled for no consideration.
F4: Represents Class B common stock and Common Units held directly by MLSH 1 after giving effect to the exchange of 8,409,946 Common Units (and cancellation of an equal number of shares of Class B common stock) for 8,409,946 shares of Class A common stock.
F5: Represents (i) 8,409,946 shares of Class A common stock sold by MLSH 1 and (ii) 1,531,028 shares of Class A common stock sold by Maravai Life Sciences Holdings 2, LLC ("MLSH 2").
F6: Represents 20,150,005 shares of Class A common stock held directly by MLSH 2.
F7: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2.
F8: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein.
Vivid Seats Inc.
Report date October 31, 2025 · Filed November 07, 2025
Jointly reported with GTCR INVESTMENT XI LLC, GTCR FUND XI/C LP, GTCR FUND XI/B LP, GTCR CO-INVEST XI LP, GTCR PARTNERS XI/B LP
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 3,768,633 |
Reported balance
Holding disclosure · report date 2025-10-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,768,633 F1: Includes (i) 753,580 shares of Class A Common Stock held by GTCR Fund XI/C LP, (ii) 2,991,081 shares of Class A Common Stock held by GTCR Fund XI/B LP and (iii) 23,972 shares of Class A Common Stock held by GTCR Co-Invest XI LP. F2: GTCR Partners XI/A&C LP is the general partner of GTCR Fund XI/C LP. GTCR Partners XI/B LP is the general partner of each of GTCR Fund XI/B LP. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI LP, GTCR Partners XI/A&C LP and GTCR Partners XI/B LP. GTCR Investment XI is managed by a board of managers (the "Board of Managers"), consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the securities reported herein. Each of the individual members of the Board of Managers disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein. |
| Class A WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $200.00 · Expires 2031-10-18 | IndirectSee Footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2025-10-31 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance Not disclosed F3: These Class A Warrants (the "$200 Warrants") are currently exchangeable for shares of Class A Common Stock on a one-to-one basis at the discretion of the holder at an exercise price of $200 per share. Includes (i) 17,881 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Fund XI/C LP, (ii) 70,975 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Fund XI/B LP and (iii) 569 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Co-Invest XI LP. F2: GTCR Partners XI/A&C LP is the general partner of GTCR Fund XI/C LP. GTCR Partners XI/B LP is the general partner of each of GTCR Fund XI/B LP. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI LP, GTCR Partners XI/A&C LP and GTCR Partners XI/B LP. GTCR Investment XI is managed by a board of managers (the "Board of Managers"), consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the securities reported herein. Each of the individual members of the Board of Managers disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein. |
| Class A WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $300.00 · Expires 2031-10-18 | IndirectSee Footnotes | Not disclosed |
Reported balance
Holding disclosure · report date 2025-10-31 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance Not disclosed F4: These Class A Warrants (the "$300 Warrants") are currently exchangeable for shares of Class A Common Stock on a one-to-one basis at the discretion of the holder at an exercise price of $300 per share. Includes (i) 17,881 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Fund XI/C LP, (ii) 70,975 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Fund XI/B LP and (iii) 569 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Co-Invest XI LP. F2: GTCR Partners XI/A&C LP is the general partner of GTCR Fund XI/C LP. GTCR Partners XI/B LP is the general partner of each of GTCR Fund XI/B LP. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI LP, GTCR Partners XI/A&C LP and GTCR Partners XI/B LP. GTCR Investment XI is managed by a board of managers (the "Board of Managers"), consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the securities reported herein. Each of the individual members of the Board of Managers disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes (i) 753,580 shares of Class A Common Stock held by GTCR Fund XI/C LP, (ii) 2,991,081 shares of Class A Common Stock held by GTCR Fund XI/B LP and (iii) 23,972 shares of Class A Common Stock held by GTCR Co-Invest XI LP.
F2: GTCR Partners XI/A&C LP is the general partner of GTCR Fund XI/C LP. GTCR Partners XI/B LP is the general partner of each of GTCR Fund XI/B LP. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI LP, GTCR Partners XI/A&C LP and GTCR Partners XI/B LP. GTCR Investment XI is managed by a board of managers (the "Board of Managers"), consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the securities reported herein. Each of the individual members of the Board of Managers disclaims beneficial ownership of the shares reported herein except to the extent of their pecuniary interest therein.
F3: These Class A Warrants (the "$200 Warrants") are currently exchangeable for shares of Class A Common Stock on a one-to-one basis at the discretion of the holder at an exercise price of $200 per share. Includes (i) 17,881 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Fund XI/C LP, (ii) 70,975 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Fund XI/B LP and (iii) 569 shares of Class A Common Stock underlying the $200 Warrants held by GTCR Co-Invest XI LP.
F4: These Class A Warrants (the "$300 Warrants") are currently exchangeable for shares of Class A Common Stock on a one-to-one basis at the discretion of the holder at an exercise price of $300 per share. Includes (i) 17,881 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Fund XI/C LP, (ii) 70,975 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Fund XI/B LP and (iii) 569 shares of Class A Common Stock underlying the $300 Warrants held by GTCR Co-Invest XI LP.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Paya Holdings Inc.
Report date February 22, 2023 · Filed February 22, 2023
Jointly reported with GTCR INVESTMENT XI LLC, GTCR-Ultra Holdings, LLC, GTCR PARTNERS XI/B LP, GTCR FUND XI/B LP, GTCR FUND XI/C LP
Section 16 reporting ended · disclosed 2023-02-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2023-02-22 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2023-02-22 · Other · Disposed 45,234,022 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Paya Holdings Inc., Nuvei Corporation ("Parent"), and Pinnacle Merger Sub, Inc., a wholly owned subsidiary of Parent dated as of January 8, 2023, these shares of common stock, par value $0.0001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive a cash payment of $9.75 per share, without interest, subject to any applicable withholding of taxes. F2: Reflects securities directly held by GTCR-Ultra Holdings, LLC ("Holdings"). GTCR Fund XI/B LP ("Fund XI/B") and GTCR Fund XI/C LP ("Fund XI/C") each hold an economic interest in Holdings and possess the right to appoint certain managers to Holdings' board of managers. Each of Fund XI/B and Fund XI/C is controlled by its general partner, GTCR Partners XI/B LP ("Partners XI/B") and GTCR Partners XI/A&C LP ("Partners XI/A&C"), respectively. Partners XI/B and Partners XI/A&C are controlled by their general partner, GTCR Investment XI LLC ("Investment XI"). As such, each of Fund XI/B, Fund XI/C, Partners XI/B, Partners XI/A&C and Investment XI may be deemed to possess indirect beneficial ownership of the Common Stock held by Holdings. Decisions of Investment XI are made by a vote of a majority of its managers, and, as a result, no single person has voting or dispositive authority over such securities. (Continued in Footnote 3). F3: Each of the foregoing entities (other than Holdings) and the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares reported hereby, except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Paya Holdings Inc., Nuvei Corporation ("Parent"), and Pinnacle Merger Sub, Inc., a wholly owned subsidiary of Parent dated as of January 8, 2023, these shares of common stock, par value $0.0001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive a cash payment of $9.75 per share, without interest, subject to any applicable withholding of taxes.
F2: Reflects securities directly held by GTCR-Ultra Holdings, LLC ("Holdings"). GTCR Fund XI/B LP ("Fund XI/B") and GTCR Fund XI/C LP ("Fund XI/C") each hold an economic interest in Holdings and possess the right to appoint certain managers to Holdings' board of managers. Each of Fund XI/B and Fund XI/C is controlled by its general partner, GTCR Partners XI/B LP ("Partners XI/B") and GTCR Partners XI/A&C LP ("Partners XI/A&C"), respectively. Partners XI/B and Partners XI/A&C are controlled by their general partner, GTCR Investment XI LLC ("Investment XI"). As such, each of Fund XI/B, Fund XI/C, Partners XI/B, Partners XI/A&C and Investment XI may be deemed to possess indirect beneficial ownership of the Common Stock held by Holdings. Decisions of Investment XI are made by a vote of a majority of its managers, and, as a result, no single person has voting or dispositive authority over such securities. (Continued in Footnote 3).
F3: Each of the foregoing entities (other than Holdings) and the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares reported hereby, except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Sotera Health Co
Report date May 13, 2026 · Filed May 15, 2026
Jointly reported with GTCR INVESTMENT XI LLC, GTCR FUND XI/A LP, GTCR FUND XI/C LP, GTCR CO-INVEST XI LP
Section 16 reporting ended · disclosed 2026-05-15. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per share ("Common Stock")SEC Table I · non-derivative | IndirectSee Footnote | 0 |
Reported balance
After 2026-05-13 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2026-05-13 · Sale · Disposed 12,735,301 · Balance 0 F1: On May 13, 2026, GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"), sold a total of 12,735,301 shares of Common Stock of Sotera Health Company in an underwritten public secondary offering. F2: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F3: Each of Partners XI/A&C, Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F4: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 13, 2026, GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"), sold a total of 12,735,301 shares of Common Stock of Sotera Health Company in an underwritten public secondary offering.
F2: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock.
F3: Each of Partners XI/A&C, Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein.
F4: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 13, 2026 Filed May 15, 2026 20:41 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 12,735,301 | $15.17 | $193,169,045.57 |
DisclosureSEC source: 0001193125-26-227029 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · shares: On May 13, 2026, GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"), sold a total of 12,735,301 shares of Common Stock of Sotera Health Company in an underwritten public secondary offering. F2 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F3 · ownership.nature: Each of Partners XI/A&C, Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F4 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 22:10 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 10,000,000 | $15.27 | $152,700,000.00 |
DisclosureSEC source: 0001193125-26-100568 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 12,735,301 F1 · shares: On March 6, 2026, the GTCR XI Funds (as defined below) sold a total of 10,000,000 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 10,107,727 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 2,546,564 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 81,010 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| December 03, 2025 Filed Dec 6, 2025 01:10 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 6,480,000 | $16.33 | $105,818,400.00 |
DisclosureSEC source: 0001193125-25-310122 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 22,735,301 F1 · shares: On December 3, 2025, the GTCR XI Funds (as defined below) sold a total of 6,480,000 shares of Common Stock of Sotera Health Company (the "Issuer"). F2 · balance_after: Following the sale, consists of (i) 18,044,507 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 4,546,174 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 144,620 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 22:06 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 12,000,000 | $15.65 | $187,812,000.00 |
DisclosureSEC source: 0001193125-25-277915 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 29,215,301 F1 · shares: On November 10, 2025, the GTCR XI Funds (as defined below) sold a total of 12,000,000 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 23,187,541 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 5,841,921 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 185,839 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| September 05, 2025 Filed Sep 10, 2025 00:41 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 8,000,000 | $15.11 | $120,888,000.00 |
DisclosureSEC source: 0001193125-25-199493 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 41,215,301 F1 · shares: On September 5, 2025, the GTCR XI Funds (as defined below) sold a total of 8,000,000 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 32,711,677 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 8,241,453 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 262,171 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| September 06, 2024 Filed Sep 9, 2024 21:36 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 10,000,000 | $15.03 | $150,300,000.00 |
DisclosureSEC source: 0001999371-24-011707 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 49,215,301 F1 · shares: On September 6, 2024, the GTCR XI Funds (as defined below) sold a total of 10,000,000 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 39,061,101 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 9,841,141 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 313,059 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| May 28, 2024 Filed May 30, 2024 17:39 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | ConversionCommon Units · Derivative | 8,409,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-066799 · ownership.xml · derivative · entry 4 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 110,684,080 Underlying: Class A common stock · 8,409,946 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · price: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · derivative.exercise_date: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · derivative.expiration_date: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · ownership.nature: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F4 · ownership.nature: Represents Class B common stock and Common Units held directly by MLSH 1 after giving effect to the exchange of 8,409,946 Common Units (and cancellation of an equal number of shares of Class B common stock) for 8,409,946 shares of Class A common stock. F7 · ownership.nature: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| May 28, 2024 Filed May 30, 2024 17:39 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | SaleClass A common stock | 9,940,974 | $9.82 | $97,570,659.81 |
DisclosureSEC source: 0000950170-24-066799 · ownership.xml · nonDerivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 20,150,005 F5 · shares: Represents (i) 8,409,946 shares of Class A common stock sold by MLSH 1 and (ii) 1,531,028 shares of Class A common stock sold by Maravai Life Sciences Holdings 2, LLC ("MLSH 2"). F6 · balance_after: Represents 20,150,005 shares of Class A common stock held directly by MLSH 2. F7 · ownership.nature: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| May 28, 2024 Filed May 30, 2024 17:39 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | ConversionClass A common stock | 8,409,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-066799 · ownership.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 30,090,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · price: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F7 · ownership.nature: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| May 28, 2024 Filed May 30, 2024 17:39 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass B common stock | 8,409,946 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-066799 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 110,684,080 F1 · kind: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F1 · price: Pursuant to the Exchange Agreement, dated as of November 19, 2020, by and among Maravai LifeSciences Holdings, Inc. (the "Issuer"), Maravai Topco Holdings, LLC ("Topco LLC") and Maravai Life Sciences Holdings, LLC ("MLSH 1") (the "Exchange Agreement"), the units in Topco LLC (the "Common Units") (together with an equal number of shares of Class B common stock, par value $0.01 per share, of the Issuer (the "Class B common stock")) are exchangeable for shares of Class A common stock, par value $0.01 per share, of the Issuer (the "Class A common stock") on a one-for-one basis. The Common Units do not expire. F2 · balance_after: Represents 110,684,080 shares of Class B common stock held directly by MLSH 1. F3 · ownership.nature: Shares of Class B common stock confer no economic rights on the holders thereof. Except as provided in the Issuer's Amended and Restated Certificate of Incorporation or as otherwise required by applicable law, holders of Class B common stock will be entitled to one vote per share on all matters to be voted on by holders of the Issuer's Class A common stock. Upon exchange of Common Units that are held by MLSH 1 and reported in Table II hereof, an equal number of shares of Class B common stock will be delivered to the Issuer and cancelled for no consideration. F4 · ownership.nature: Represents Class B common stock and Common Units held directly by MLSH 1 after giving effect to the exchange of 8,409,946 Common Units (and cancellation of an equal number of shares of Class B common stock) for 8,409,946 shares of Class A common stock. F7 · ownership.nature: MLSH 1 and MLSH 2 are each managed by a board of managers. GTCR Fund XI/C LP ("GTCR Fund XI/C") controls the board of managers of MLSH 2. GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI") control the board of managers of MLSH 1. GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of each of GTCR Co-Invest XI, GTCR Partners XI/A&C and GTCR Partners XI/B. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A common stock or Class B common stock held of record by MLSH 1 and MLSH 2. F8 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class A common stock held of record by MLSH 2. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Class B common stock held of record by MLSH 1 and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares held of record by MLSH 1 and MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:35 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 11,062,908 | $14.31 | $158,282,556.21 |
DisclosureSEC source: 0001999371-24-003174 · sotera-form4_030424.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 59,215,301 F1 · shares: On March 4, 2024, the GTCR XI Funds (as defined below) sold a total of 11,062,908 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 46,997,881 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 11,840,751 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 376,669 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| February 22, 2023 Filed Feb 22, 2023 16:19 UTC | Paya Holdings Inc. PAYA · Entity 116479 | OtherCommon Stock | 45,234,022 | $9.75 | $441,031,714.50 |
DisclosureSEC source: 0001213900-23-013686 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR-Ultra Holdings, LLC · CIK 0001714612 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Paya Holdings Inc., Nuvei Corporation ("Parent"), and Pinnacle Merger Sub, Inc., a wholly owned subsidiary of Parent dated as of January 8, 2023, these shares of common stock, par value $0.0001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive a cash payment of $9.75 per share, without interest, subject to any applicable withholding of taxes. F1 · price: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement") by and among Paya Holdings Inc., Nuvei Corporation ("Parent"), and Pinnacle Merger Sub, Inc., a wholly owned subsidiary of Parent dated as of January 8, 2023, these shares of common stock, par value $0.0001 per share were tendered prior to the Offer Expiration Time (as defined in the Merger Agreement) and disposed of at the Effective Time (as defined in the Merger Agreement) in exchange for the right to receive a cash payment of $9.75 per share, without interest, subject to any applicable withholding of taxes. F2 · ownership.nature: Reflects securities directly held by GTCR-Ultra Holdings, LLC ("Holdings"). GTCR Fund XI/B LP ("Fund XI/B") and GTCR Fund XI/C LP ("Fund XI/C") each hold an economic interest in Holdings and possess the right to appoint certain managers to Holdings' board of managers. Each of Fund XI/B and Fund XI/C is controlled by its general partner, GTCR Partners XI/B LP ("Partners XI/B") and GTCR Partners XI/A&C LP ("Partners XI/A&C"), respectively. Partners XI/B and Partners XI/A&C are controlled by their general partner, GTCR Investment XI LLC ("Investment XI"). As such, each of Fund XI/B, Fund XI/C, Partners XI/B, Partners XI/A&C and Investment XI may be deemed to possess indirect beneficial ownership of the Common Stock held by Holdings. Decisions of Investment XI are made by a vote of a majority of its managers, and, as a result, no single person has voting or dispositive authority over such securities. (Continued in Footnote 3). F3 · ownership.nature: Each of the foregoing entities (other than Holdings) and the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares reported hereby, except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 16:05 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerCommon Units · Derivative | 2,570,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000472 · doc4.xml · derivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 123,669,196 Underlying: Class A Common Stock · 2,570,415 shares Expires not disclosed F5 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of the Issuer's Class A common stock, par value $0.01 per share (the "Class A Common Stock"). Common Units do not expire. F5 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of the Issuer's Class A common stock, par value $0.01 per share (the "Class A Common Stock"). Common Units do not expire. F5 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of the Issuer's Class A common stock, par value $0.01 per share (the "Class A Common Stock"). Common Units do not expire. F6 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 16:05 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass B Common Stock | 2,570,415 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-000472 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 123,669,196 F3 · ownership.nature: Reflects shares of the Issuer's Class B Common Stock, par value $0.01 per share (the "Class B Common Stock"), held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. F4 · ownership.nature: (Continued From Footnote 3) Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of the pecuniary interest therein. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerCommon Units · Derivative | 17,068,559 | $50.00 | $853,427,950.00 |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · derivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,239,611 Underlying: Class A Common Stock · 17,068,559 shares Expires not disclosed F6 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F6 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F6 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | OtherClass B Common Stock | 17,068,559 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 126,239,611 F4 · kind: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F4 · shares: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F4 · price: Reflects the shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") exchanged for shares of Class A Common Stock sold. F5 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| September 09, 2021 Filed Sep 13, 2021 16:21 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass A Common Stock | 2,931,441 | $50.00 | $146,572,050.00 |
DisclosureSEC source: 0000899243-21-035674 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 21,681,033 F1 · kind: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F1 · shares: On September 9, 2021, the Reporting Persons sold an aggregate 20,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-259366). The aggregate 20,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 17,068,559 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,931,441 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). F2 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F3 · balance_after: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F2 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F3 · ownership.nature: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerCommon Units · Derivative | 2,304,256 | $31.25 | $72,008,000.00 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · derivative · entry 6 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 143,308,170 Underlying: Class A Common Stock · 2,304,256 shares Expires not disclosed F7 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F7 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F8 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | OtherClass B Common Stock | 2,304,256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 4 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 143,308,170 F5 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F6 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F6 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| April 08, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass A Common Stock | 395,744 | $31.25 | $12,367,000.00 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 24,612,474 F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F1 · shares: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · shares: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F3 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · balance_after: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · ownership.nature: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerCommon Units · Derivative | 15,361,703 | $31.25 | $480,053,218.75 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · derivative · entry 5 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 145,612,426 Underlying: Class A Common Stock · 15,361,703 shares Expires not disclosed F7 · derivative.exercise_price: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F7 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F7 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Maravai Topco Holdings, LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one share of Class B Common Stock for every Common Unit) are exchangeable for one share of Class A Common Stock. Common Units do not expire. F8 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one share of Class A Common Stock pursuant to the Exchange Agreement. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | OtherClass B Common Stock | 15,361,703 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 145,612,426 F5 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Common Stock") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F6 · balance_after: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. F6 · ownership.nature: Reflects Class B Common Stock held directly by MLSH 1. MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Common Stock. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B Common Stock held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B Common Stock held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| April 07, 2021 Filed Apr 9, 2021 17:00 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass A Common Stock | 2,638,297 | $31.25 | $82,446,781.25 |
DisclosureSEC source: 0000899243-21-015484 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 25,008,218 F1 · kind: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · kind: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F1 · shares: On April 7, 2021, the Reporting Persons sold an aggregate 18,000,000 shares of Class A common stock, par value $0.01 ("Class A Common Stock"), of Maravai LifeSciences Holdings, Inc. (the "Issuer") in an underwritten public offering pursuant to the Issuer's Registration Statement on Form S-1 (File No. 333-255043). The aggregate 18,000,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 15,361,703 shares of Class A Common Stock sold by Maravai Life Sciences Holdings, LLC ("MLSH 1") and (b) 2,638,297 shares of Class A Common Stock sold by Maravai Life Sciences Holdings 2, LLC. ("MLSH 2"). On April 8, 2021, the Reporting Persons sold an aggregate of 2,700,000 shares of Class A Common Stock of the Issuer pursuant to the option granted to the underwriters, which was exercised in full prior to closing. F2 · shares: (Continued from footnote 1) The aggregate 2,700,000 shares of Class A Common Stock sold by the Reporting Persons include (a) 2,304,256 shares of Class A Common Stock sold by MLSH 1 and (b) 395,744 shares of Class A Common Stock sold by MLSH 2. F3 · balance_after: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · balance_after: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. F3 · ownership.nature: Reflects Class A Common Stock held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Common Stock. F4 · ownership.nature: (Continued From Footnote 3) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Common Stock held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Common Stock held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
| March 22, 2021 Filed Mar 24, 2021 09:16 UTC | Paya Holdings Inc. PAYA · Entity 116479 | SaleCommon Stock | 10,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001213900-21-017413 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 45,234,022 F1 · shares: Represents common stock of Paya Holdings Inc. (the "Issuer") sold by GTCR-Ultra Holdings, LLC ("Ultra") pursuant to the offering of Issuer common stock on Form S-1 as contemplated by that certain underwriting agreement, dated March 17, 2021, among the Issuer, Ultra and the underwriters named therein. The selling price of such shares was $11.72937 per share, which represents the price to public less the underwriting discount. F1 · price: Represents common stock of Paya Holdings Inc. (the "Issuer") sold by GTCR-Ultra Holdings, LLC ("Ultra") pursuant to the offering of Issuer common stock on Form S-1 as contemplated by that certain underwriting agreement, dated March 17, 2021, among the Issuer, Ultra and the underwriters named therein. The selling price of such shares was $11.72937 per share, which represents the price to public less the underwriting discount. F2 · ownership.nature: Voting and dispositive power with respect to the shares of common stock held by Ultra is exercised by GTCR Investment XI LLC ("Investment XI"). Voting and dispositive power with respect to the shares of common stock held by Fund XI/B is exercised by its general partner, GTCR Partners XI/B LP ("Partners XI/B"). Voting and dispositive power with respect to the shares of common stock held by Fund XI/C is exercised by its general partner, GTCR Partners XI/A&C LP ("Partners XI/A&C"). Investment XI is the general partner of each of Co-Invest, Partners XI/B and Partners XI/A&C. GTCR Investment XI LLC is managed by an eight-member board of managers (the "GTCR Board of Managers") (Continued in Footnote 3). F3 · ownership.nature: Each of the foregoing entities and the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares reported hereby, except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. Read SEC document |
| March 22, 2021 Filed Mar 25, 2021 00:57 UTC | Sotera Health Co SHC · Entity 3869 | SaleCommon Stock, $0.01 par value per share ("Common Stock") | 9,008,388 | $26.12 | $235,321,615.53 |
DisclosureSEC source: 0001387131-21-003869 · ownership.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner GTCR FUND XI/A LP · CIK 0001591434 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 70,278,209 F1 · shares: On March 22, 2021, the GTCR XI Funds (as defined below) sold a total of 9,008,388 shares of Common Stock of Sotera Health Company (the "Issuer") in an underwritten public secondary offering (the "Offering"). F2 · balance_after: Following the Offering, consists of (i) 55,778,268 shares of Common Stock held directly by GTCR Fund XI/A LP, a Delaware limited partnership ("Fund XI/A"), (ii) 14,052,901 shares of Common Stock held directly by GTCR Fund XI/C LP, a Delaware limited partnership ("Fund XI/C"), and (iii) 447,040 shares of Common Stock held directly by GTCR Co-Invest XI LP, a Delaware limited partnership ("Co-Invest XI", and together with Fund XI/A and Fund XI/C, the "GTCR XI Funds"). F3 · ownership.nature: GTCR Partners XI/A&C LP ("Partners XI/A&C") is the general partner of each of Fund XI/A and Fund XI/C. GTCR Investment XI LLC ("Investment XI" and together with the GTCR XI Funds and Partners XI/A&C, the "GTCR Entities"), is the general partner of Co-Invest XI and Partners XI/A&C. Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the shares of Common Stock. F4 · ownership.nature: Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the shares of Common Stock held of record by the GTCR XI Funds except to the extent of his pecuniary interest therein. F5 · ownership.nature: Each of the reporting persons is a director-by-deputization solely for purposes of Section 16 of the Exchange Act. Information with respect to each of the GTCR Entities is given solely by such GTCR Entity, and no GTCR Entity has responsibility for the accuracy or completeness of information supplied by another GTCR Entity. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerCommon Units · Derivative | 55,823,011 | $25.52 | $1,424,324,125.67 |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · derivative · entry 3 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,974,129 Underlying: Class A Common Stock · 160,974,129 shares Expires not disclosed F7 · derivative.exercise_price: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one Class A Share pursuant to the Exchange Agreement. F1 · kind: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F1 · shares: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F6 · derivative.exercise_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Topco LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one Class B Share for every Common Unit) are exchangeable for one Class A Share. Common Units do not expire. F6 · derivative.expiration_date: Pursuant to the Exchange Agreement dated November 19, 2020, by and among the Issuer, Topco LLC and MLSH 1 (the "Exchange Agreement"), the Common Units (together with one Class B Share for every Common Unit) are exchangeable for one Class A Share. Common Units do not expire. F7 · ownership.nature: Reflects Common Units owned directly by MLSH 1. Each Common Unit is exchangeable for one Class A Share pursuant to the Exchange Agreement. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | OtherClass B Common Stock | 7,680,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · nonDerivative · entry 2 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 160,974,129 F4 · kind: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F4 · shares: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F4 · price: Reflects shares of the Issuer's Class B common stock, par value $0.01 (the "Class B Shares") forfeited and canceled for no consideration by MLSH 1 in connection with the purchase by the Issuer of the Common Units. F5 · balance_after: Reflects Class B Shares held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Shares. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B shares held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B shares held of record by MLSH 1 except to the extent of his pecuniary interest therein. F5 · ownership.nature: Reflects Class B Shares held directly by Maravai Life Sciences Holdings, LLC ("MLSH 1"). MLSH 1 is managed by a board of managers controlled by GTCR Fund XI/B LP ("GTCR Fund XI/B") and GTCR Co-Invest XI LP ("GTCR Co-Invest XI"). GTCR Partners XI/B LP ("GTCR Partners XI/B") is the general partner of GTCR Fund XI/B. GTCR Investment XI is the general partner of GTCR Co-Invest XI and GTCR Partners XI/B. GTCR Investment XI is managed by the GTCR Board of Managers, and no single person has voting or dispositive authority over the Class B Shares. Each of GTCR Partners XI/B, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class B shares held of record by MLSH 1, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class B shares held of record by MLSH 1 except to the extent of his pecuniary interest therein. Read SEC document |
| November 24, 2020 Filed Nov 27, 2020 16:43 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | Disposition to issuerClass A Common Stock | 1,319,148 | $25.52 | $33,658,061.22 |
DisclosureSEC source: 0000899243-20-032274 · doc4.xml · nonDerivative · entry 1 GTCR INVESTMENT XI LLC · CIK 0001827977 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS, LLC · CIK 0001833157 · Director · 10% owner MARAVAI LIFE SCIENCES HOLDINGS 2, LLC · CIK 0001832794 · Director · 10% owner GTCR FUND XI/B LP · CIK 0001591435 · Director · 10% owner GTCR FUND XI/C LP · CIK 0001591436 · Director · 10% owner GTCR CO-INVEST XI LP · CIK 0001591432 · Director · 10% owner GTCR PARTNERS XI/A&C LP · CIK 0001828028 · Director · 10% owner GTCR PARTNERS XI/B LP · CIK 0001827959 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 27,646,515 F1 · kind: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F1 · shares: On November 24, 2020, the Issuer used a portion of the net proceeds from the closing of its initial public offering ("IPO") of Class A common stock, par value $0.01 per share (the "Class A Shares"), to repurchase 1,319,148 Class A Shares held by Maravai Life Sciences Holdings 2, LLC ("MLSH 2") and to purchase 55,823,011 common units (the "Common Units") of Maravai Topco Holdings, LLC ("Topco LLC") from Maravai Life Sciences Holdings , LLC ("MLSH 1"), who were the Issuer's pre-IPO equityholders, at a price of $25.5150 per Class A Share or Common Unit. F2 · balance_after: Reflects Class A Shares held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Shares. F3 · balance_after: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Shares held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Shares held of record by MLSH 2 except to the extent of his pecuniary interest therein. F2 · ownership.nature: Reflects Class A Shares held directly by MLSH 2. MLSH 2 is managed by a board of managers controlled by GTCR Fund XI/C LP ("GTCR Fund XI/C"). GTCR Partners XI/A&C LP ("GTCR Partners XI/A&C") is the general partner of GTCR Fund XI/C. GTCR Investment XI LLC ("GTCR Investment XI") is the general partner of GTCR Partners XI/A&C. GTCR Investment XI is managed by a board of managers (the "GTCR Board of Managers") consisting of Mark M. Anderson, Craig A. Bondy, Aaron D. Cohen, Sean L. Cunningham, Benjamin J. Daverman, David A. Donnini, Constantine S. Mihas and Collin E. Roche, and no single person has voting or dispositive authority over the Class A Shares. F3 · ownership.nature: (Continued From Footnote 2) Each of GTCR Partners XI/A&C, GTCR Investment XI and the GTCR Board of Managers may be deemed to share beneficial ownership of the Class A Shares held of record by MLSH 2, and each of the individual members of the GTCR Board of Managers disclaims beneficial ownership of the Class A Shares held of record by MLSH 2 except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.